Christoph Reißfelder
Dresden University of Technology
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Christoph Reißfelder.
Oncotarget | 2015
Mathieu Pecqueux; Johannes Fritzmann; Mariam Adamu; Kristian Thorlund; Christoph Kahlert; Christoph Reißfelder; Jürgen Weitz; Nuh N. Rahbari
Purpose Despite continuously improving therapies, gastric cancer still shows poor survival in locally advanced stages with local recurrence rates of up to 50% and peritoneal recurrence rates of 17% after curative surgery. We performed a systematic review with meta-analyses to clarify whether positive intraperitoneal cytology (IPC) indicates a high risk of disease recurrence and poor overall survival in gastric cancer. Methods Multiple databases were searched in December 2014 to identify studies on the prognostic significance of positive intraperitoneal cytology in gastric cancer, including: Medline, Biosis, Science Citation Index, Embase, CCMed and publisher databases. Hazard ratios (HR) and associated 95% confidence intervals (CI) were extracted from the identified studies. A meta-analysis was performed using a random-effects model on overall survival, disease-free survival and peritoneal recurrence free survival. Results A total of 64 studies with a cumulative sample size of 12,883 patients were included. Cytology, quantitative real time polymerase chain reaction (PCR) or both were performed in 35; 21 and 8 studies, respectively. Meta analyses revealed free intraperitoneal tumor cells (FITC) to be associated with poor overall survival in univariate (HR 3.27; 95% CI 2.82 - 3.78]) and multivariate (HR 2.45; 95% CI 2.04 - 2.94) analysis and poor peritoneal recurrence free survival in univariate (4.15; 95% CI 3.10 - 5.57) and multivariate (3.09; 95% CI 2.02 - 4.71) analysis. Subgroup analysis showed this effect to be independent of the detection method, Western or Asian origin or the time of publication. Conclusions FITC oder positive peritoneal cytology is associated with poor survival and increased peritoneal recurrence in gastric cancer.
Langenbeck's Archives of Surgery | 2013
Johanna Kirchberg; Christoph Reißfelder; Jürgen Weitz; Moritz Koch
IntroductionDespite initial concerns regarding safety and oncological adequacy, the use of laparoscopic liver resections for benign and malignant diseases has spread worldwide. As in open liver surgery, anatomical orientation and the ability to control intraoperative challenges as bleeding have to be combined with expertise in advanced laparoscopic techniques.MethodsIn this review, we provide an overview regarding the literature on laparoscopic liver resection for benign and malignant liver tumors with the aim to discuss the current standards and define remaining challenges. Although numerous case series and meta-analyses have addressed the evolving field of laparoscopic liver surgery recently, data from randomized controlled trials are still not available.Results and conclusionsLaparoscopic liver resection is feasible and safe in selected patients and experienced hands. Even major liver resections can be performed laparoscopically. The minimal invasive approach offers benefits in perioperative short-term outcome without compromising oncological outcomes compared to open liver resections. Further randomized trials are needed to formally prove these statements and to define the optimal indication and techniques for the individual patient.
Archive | 2015
Christoph Reißfelder; Jürgen Weitz
Die abdominoperineale Rektumexstirpation (APE) nach Holm beschreibt die Technik der extralevatorischen Resektion eines tief sitzenden Rektumkarzinoms. Der Unterschied zur normalen APE ist die zirkumferentielle Ausdehnung der Operation im Bereich des M. puborectalis und des M. levator ani, sodass am Praparat (klassischerweise 3 bis 4 cm oral der Anokutanlinie) keine Taille entsteht. Die abdominale Resektionsphase endet bevor man bei der Dissektion des Mesorektums die Steisbeinspitze erreicht. Erst im folgenden, perinealen Teil der Operation wird das ischiorektale Fettgewebe und der M. levator ani durchtrennt und das Praparat geborgen. Im Folgenden sind die einzelnen Operationsschritte dargestellt.
Archive | 2013
Michael Korenkov; Christoph-Thomas Germer; Hauke Lang; M. Anthuber; Alexis Ulrich; Markus W. Büchler; Alois Fürst; Arthur Heiligensetzer; Peter Sauer; Gudrun Liebig-Hörl; Werner Hohenberger; Pierluigi Angelini; Kim Erlend Mortensen; Rolv-Ole Lindsetmo; Jurriaan Tuynman; Neil J. Mortensen; Amjad Parvaiz; Manfred Odermatt; Hans-Rudolf Raab; Achim Troja; Dalibor Antolovic; P. M. Sagar; Jürgen Weitz; Christoph Reißfelder; Steven D. Wexner; Marc C. Osborne; W. Kneist; Arnulf Thiede; Hans-Joachim Zimmermann; Stig Norderval
Die anteriore oder tiefe anteriore Rektumresektion in Kombination mit einer partiellen (PME) oder totalen mesorektalen Exzision (TME) sind die derzeitigen Standardverfahren in der Chirurgie der Rektumkarzinome. Diese Operationen werden laparoskopisch oder in konventioneller Technik durchgefuhrt. Die wesentlichen Phasen der Operation sind: 1. Mobilisierung von Sigma und Colon descendens; 2. Durchtrennung der A. und V. mesenterica inferior; 3. Durchtrennung des Colon descendens; 4. Mobilisierung des Rektums in PME- oder TME-Technik; 5. Absetzen des Rektums; 6. Anastomosierung; 7. Anlage eines protektiven Stomas (optional). Technische Probleme und schwierige Entscheidungssituationen entstehen meistens bei der ventralen Praparation im kleinen Becken, beim Absetzen des Rektums und bei der Anastomosierung.
Zentralblatt Fur Chirurgie | 2014
Christoph Reißfelder; J. Kirchberg; Jürgen Weitz
Zentralblatt Fur Chirurgie | 2018
Nadine Oppermann; Jürgen Weitz; Christoph Reißfelder; Sören Torge Mees
Langenbeck's Archives of Surgery | 2016
Andreas Volk; Philipp Nitschke; Franziska Johnscher; Nuh N. Rahbari; Thilo Welsch; Christoph Reißfelder; Jürgen Weitz; Marius Distler; Soeren Torge Mees
Zentralblatt Fur Chirurgie | 2018
Jakob Dobroschke; Tina Groß; Jürgen Weitz; Christoph Reißfelder
OncoImmunology | 2018
Armin Jarosch; Ulrich Sommer; Andreas Bogner; Christoph Reißfelder; Jürgen Weitz; Mechthild Krause; Gunnar Folprecht; Gustavo Baretton; Daniela Aust
Intensivmedizin Up2date | 2018
Theresa Meißner; Christoph Reißfelder